Analgesics, Corticosteroids, and Anti-Gout Medications

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/17

flashcard set

Earn XP

Description and Tags

Vocabulary practice flashcards covering WHO analgesic ladder principles, opioid classifications, corticosteroids, DMARDs, and antigout medications from the lecture notes.

18 Terms

1
New cards

By the Mouth (WHO Analgesic Ladder Principle)

The principle stating that analgesics should be administered orally whenever possible because oral medications are convenient, less invasive, more cost-effective, and preferred by most patients.

2
New cards

By the Clock (WHO Analgesic Ladder Principle)

The principle stating that pain medications must be given at regular scheduled intervals rather than only when the patient complains of pain, with breakthrough pain managed using rescue doses.

3
New cards

By the Ladder (WHO Analgesic Ladder Principle)

A treatment approach selecting therapy by pain intensity: Step 1 for mild pain (score 1–31\text{--}3), Step 2 for moderate pain (score 4–64\text{--}6), Step 3 for severe pain (score 7–107\text{--}10), and Step 4 for interventional pain management.

4
New cards

Tramadol

A weak opioid (brand names Tramal®, Dolcet®) that acts as a weak μ\mu-opioid receptor agonist and inhibits serotonin and norepinephrine reuptake; used for moderate to moderately severe pain.

5
New cards

Morphine

A strong opioid (brand names MS Contin®, Roxanol®) that acts as a strong μ\mu-opioid receptor agonist to inhibit pain transmission in the CNS; indicated for severe acute pain, cancer pain, and postoperative pain.

6
New cards

Fentanyl

A potent opioid (brand names Durogesic®, Sublimaze®) acting as a potent μ\mu-opioid receptor agonist that produces profound analgesia; indicated for severe chronic pain, anesthesia adjunct, and breakthrough cancer pain.

7
New cards

Hydrocortisone

A short-acting glucocorticoid (brand names Cortef®, Solu-Cortef®) that binds intracellular glucocorticoid receptors, suppressing phospholipase A2A_2 and inflammatory cytokines, thereby decreasing prostaglandin and leukotriene synthesis.

8
New cards

Prednisone

An intermediate-acting glucocorticoid (brand name Deltasone®) that suppresses inflammation by inhibiting leukocyte migration and inflammatory mediator production; indicated for conditions such as rheumatoid arthritis, lupus, asthma, and COPD exacerbations.

9
New cards

Methylprednisolone

An intermediate-acting glucocorticoid (brand names Medrol®, Solu-Medrol®) with potent anti-inflammatory and immunosuppressive actions that inhibits leukocyte infiltration and cytokine production.

10
New cards

Dexamethasone

A long-acting, highly potent glucocorticoid (brand name Decadron®) that suppresses inflammatory cytokines and immune cell activity; indicated for cerebral edema, severe allergies, and COVID-19 requiring oxygen.

11
New cards

Fludrocortisone

A mineralocorticoid (brand name Florinef®) that increases sodium and water reabsorption while increasing potassium excretion in the renal distal tubules, expanding blood volume and blood pressure.

12
New cards

Methotrexate

A conventional synthetic DMARD and antimetabolite (brand names Methotrexate Ebewe®, Metoject®, Trexall®) dosed once weekly; inhibits dihydrofolate reductase to decrease DNA synthesis and suppress T- and B-cell activity.

13
New cards

Hydroxychloroquine

A conventional synthetic DMARD and antimalarial (brand name Plaquenil®) that inhibits antigen presentation and cytokine release; requires regular ophthalmologic monitoring due to the risk of retinopathy.

14
New cards

Cyclosporine

A calcineurin inhibitor immunosuppressant DMARD (brand names Sandimmun®, Neoral®) that blocks calcineurin to prevent T-cell activation and cytokine production, especially IL-2; associated with gingival hyperplasia, hirsutism, and nephrotoxicity.

15
New cards

Tocilizumab

A biological DMARD (brand name Actemra®) functioning as an IL-6 receptor antagonist by binding to and blocking IL-6 receptors; contraindicated if absolute neutrophil count is <2,000/mm3< 2{,}000/\text{mm}^3 or platelets are <100,000/mm3< 100{,}000/\text{mm}^3.

16
New cards

Colchicine

An antigout anti-inflammatory agent (brand names Colgout®, Colchicine LPH®, Colchicine Sandoz®) that binds to tubulin to inhibit microtubule polymerization and neutrophil migration; treats acute gout attacks without lowering serum uric acid.

17
New cards

Allopurinol

A xanthine oxidase inhibitor (brand names Zyloric®, Allurase®, Puricos®) that reduces serum uric acid levels by inhibiting the enzymatic conversion of hypoxanthine and xanthine into uric acid.

18
New cards

Febuxostat

A selective xanthine oxidase inhibitor (brand names Adenuric®, Feburic®) that decreases uric acid production for chronic hyperuricemia in gout patients, especially those intolerant to allopurinol.